Better Business Bureau

Charity Contact Information BBB Wise Giving Alliance Comments Programs

Tax Status Governance Fund Raising Financial

Name:	Alpha-1 Foundation
Address:	2937 SW 27th Avenue, Suite 302
	Miami, FL 33133
Phone:	305-507-9888 305-567-9888
Web Address:	www.alphaone.org

Alpha-1 Foundation (the Foundation) meets the 20 Standards for Charity Accountability.

The Foundation reports that it operates about 60 clinical resource centers that provide patient care and education for persons with pulmonary illnesses and/or liver conditions associated with Alpha-1 Antitrypsin Deficiency (AAT). The Foundation works with Alpha-1 investigators and funds an Alpha-1 research registry, DNA and tissue bank, and genetics laboratory, as well as academic and/or clinical research programs. It also organizes scientific meetings, conferences, workshops and symposia. Categories of grants and awards are available from the Foundation for meritorious projects including clinical treatment, pilot and feasibility, postdoctoral research fellowship, and ethical, legal and social issues relating to AAT Deficiency. AAT testing kits are distributed through a partnership with the Florida Department of Health and the University of Florida. The Foundation promotes awareness of AAT among the medical profession and public, with a focus on educating and recommending Alpha-1 testing for high-risk individuals, such as those diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and unexplained liver disease. In the arena of public policy, the Foundation monitors legislative and regulatory issues and stakes positions on such issues as increased research funding, new therapeutics, screening and detection, access to care, medical privacy, genetic non-discrimination, and blood product safety.

For the fiscal year ended June 30, 2010, the Foundation's program expenses were:

COPD Foundation, Inc.	3,573,843
Alpha-1 research network	2,176,823
Other Alpha-1 services	552,460
Florida detection program	321,449
Alpha-1 registry and ACT trial	247,265
PFT study	228,217
Alpha-1 advocacy	174,375
The Alpha-1 project	134,002
Respiratory logistics	114,141
Total Program Expenses:	$7,522,575

Chief Executive : John W. Walsh, President and Chief Executive Officer

Compensation*:

$200,000

Chair of the Board: Albert Rees
Chair's Profession / Business Affiliation: Retired Railroad Executive

Board Size: 11

Paid Staff Size: 15

*July 1, 2009 - June 30, 2010 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.

Method(s) Used:

Direct mail, special events, grant proposals, Internet appeals, planned giving, and cause-related marketing.

Fund raising costs were 10% of related contributions. (Related contributions, which totaled $10,016,137, are donations received as a result of fund raising activities.)

This organization is tax-exempt under section 501(c)(3) of the Internal Revenue Code. It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.

The following information is based on the Foundation's audited financial statements (consolidated with affiliates) for the fiscal year ended June 30, 2010.

Source of Funds
Contributions, bequests and grant revenues	8,345,595
Donated shares	1,013,200
Other income	963,199
Special events revenues	657,342
Investment income	85,324
Total Income	$11,064,660

Uses of Funds as a % of Total Expenses

Programs: 81%  Fund Raising: 11%  Administrative: 8%

Total income				$11,064,660
	Program expenses			$7,522,575
	Fund raising expenses			1,001,134
	Administrative expenses			691,150
Total expenses				$9,214,859
Income in Excess of Expenses				1,849,801
Beginning net assets				8,216,633
Ending net assets				10,066,434
Total liabilities				1,461,194
Total assets				$11,527,628